| Pharmaceutical active ingredients: |
| DydrogesteroneEstradiol |
| Available forms, composition and doses of Femphascyl Conti: |
| N / A |
| Femphascyl Conti medical category: |
| Human:Oestrogens and progesterones and related synthetic drugs |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| G03FA14 - Dydrogesterone and estrogen |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Solvay |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Retrone | Dydrogesterone | Unidentified Pharmaceutical Company |
| Terolut | Dydrogesterone | Solvay; Algol Pharma |
| Femapak | Dydrogesterone; Estradiol | Solvay |
| Femaston | Dydrogesterone; Estradiol | Solvay |
| Femphascyl | Dydrogesterone; Estradiol | Solvay |
| Lutalmin | Dydrogesterone; Estradiol | Offenbach Mexicana |
| Zumeston | Dydrogesterone; Estradiol | Solvay |
| Climaston | Dydrogesterone; Estradiol Hemihydrate | Solvay |
| Femoston | Dydrogesterone; Estradiol Hemihydrate | Solvay; Algol Pharma; Edward Keller; Grunenthal; Pharmaforte; Sime Darby Marketing; Zuellig Pharma |
| Femoston 1 / 10 | Dydrogesterone; Estradiol Hemihydrate | Solvay; DKSH; The Glory Medicina |